admin

Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub Saharan Africa: Learnings for Other Global Health Interventions? Dott. C. Medri Management of Hemoglobinopathy diagnostic and Hemoglobinopathy Hematology, Laboratory diagnostic (incl. morphology, flow-cytometry and transfusion medicine)Swiss National Science Foundation SNSF This article is part of the GARDEN Experts…

Gene Therapy in Thalassemia and Sickle Cell Disease: From Clinical Trials to Real-World UK Practice Dr Josu de la Fuente PhD FRCP FRCPI FRCPCH FRCPath Consultant Paediatric Haematologist – Harley Street Paediatric Group London This article is part of the GARDEN Experts Insights series, featuring key perspectives from leading international…

Current and Ongoing Innovative Treatments in Paroxysmal Nocturnal Hemoglobinuria Elena SolomouMD, PhDProfessor Internal Medicine-HematologyUniversity of Patras Medical School, Greece This article is part of the GARDEN Experts Insights series, featuring key perspectives from leading international experts who contribute to GARDEN educational initiatives and webinars.In this edition, Professor Elena Solomou explores…

Targeting Chronic Anemia in Thalassemia: The Emerging Role of Mitapivat as a Disease-Modifying Therapy Kevin H.M. Kuo, MD, MSc, FRCPCAssociate ProfessorDivision of Hematology, Department of Medicine, Faculty of Medicine, University of TorontoInstitute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto   This article…

Highlights and Concerns in Thrombotic thrombocytopenic purpura TTP Treatment: From Pathophysiology to the Era of Caplacizumab Raimondo De Cristofaro, Associate Professor of Internal Medicine, Faculty of Medicine and Surgery “A. Gemelli”, Università Cattolica del Sacro Cuore (Rome, Italy)   This article is part of the Garden Experts Insights series, featuring…

Rethinking Evidence in Hemophilia Care: A Critical Analysis of International Consensus Guidelines Cedric Hermans, MD, PhD, FRCP(Lon, Edin)Full Professor, Head Haemostasis and Thrombosis UnitHaemophilia Clinic Division of Adult Haematology St-Luc University Hospital (Brussels), Vice-President Medical of the WFH Continuing our editorial series featuring insights from leading experts participating in GARDEN…

Extended Half-Life Therapies: What Real-World Practice Shows Mariasanta Napolitano, MD, PhD PROMISE Department, University of Palermo, Palermo, Italy Haematology and Rare Disease Unit, “V. Cervello” Hospital, Palermo, Italy This article opens a series of contributions featuring insights from speakers at our ECM webinars, now presented as editorial content. We begin…